Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Rebecca K. Viscusi"'
Autor:
Michelle E. Melisko, Kirsten K. Edmiston, HS Han, W. Fraser Symmans, Gregor Krings, Molly Klein, Rita Nanda, Claudine Isaacs, Rebecca K. Viscusi, Sunati Sahoo, David M. Euhus, Jeffrey B. Matthews, Angela DeMichele, Erica Stringer-Reasor, Qamar J. Khan, Laura J. van't Veer, Tara Sanft, Christina Yau, Donald A. Berry, Richard Schwab, Janice Lu, Jane Perlmutter, A. Jo Chien, Donald W. Northfelt, Anne M. Wallace, Zaha Mitri, Jane L. Meisel, Julie E. Lang, Jodi M. Carter, Lajos Pusztai, Hope S. Rugo, Rachel L. Yung, Erin D. Ellis, Anthony D. Elias, Laila Khazai, Kathy S. Albain, Yunn-Yi Chen, Nola M. Hylton, Amy S. Clark, Laura J. Esserman, Christos Hatzis, Judy C. Boughey, Douglas Yee, Kimberly Cole, Dina Kokh
Publikováno v:
Cancer Research. 80:P2-20
Background: Achieving a pathologic complete response (pCR) has been shown on the patient level to predict excellent long-term event-free survival outcomes. Residual cancer burden (RCB) quantifies the extent of residual disease for patients who did no
Autor:
Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa G Steenbruggen, Maartje van Seijen, Jelle Wesseling, Miguel Martín, Maria del Monte-Millán, Sara López-Tarruella, Judy C Boughey, Matthew P Goetz, Tanya Hoskin, Rebekah Gould, Vicente Valero, Stephen B Edge, Jean E Abraham, John M S Bartlett, Carlos Caldas, Janet Dunn, Helena Earl, Larry Hayward, Louise Hiller, Elena Provenzano, Stephen-John Sammut, Jeremy S Thomas, David Cameron, Ashley Graham, Peter Hall, Lorna Mackintosh, Fang Fan, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela M DeMichele, Kimberly Cole, Lajos Pusztai, Mi-Ok Kim, Laura J van 't Veer, Laura J Esserman, W Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita M. Asare, Ron Balassanian, Heather Beckwith, Scott M. Berry, Donald A. Berry, Judy C. Boughey, Meredith B. Buxton, Yunn-Yi Chen, Beiyun Chen, A. Jo Chien, Stephen Y. Chui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Angela M. DeMichele, Xiuzhen Duan, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, Laura L. Esserman, David M. Euhus, Oluwole Fadare, Michael D Feldman, Andres Forero-Torres, Barbara B. Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly E. Klein, Gregor Krings, Julie E. Lang, Lauren G. LeBeau, Brian Leyland-Jones, Minetta C. Liu, Shelly Lo, Janice Lu, Anthony Magliocco, Jeffrey B. Matthews, Michelle E. Melisko, Paulette Mhawech-Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris T. Ocal, Olufunmilayo Olopade, Stefan Pambuccian, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Garry Peterson, Mara Rendi, Hope S. Rugo, Sunati Sahoo, Sharon Sams, Ashish Sanil, Husain Sattar, Richard B. Schwab, Ruby Singhrao, Katherine Steeg, Erica Stringer-Reasor, W. Fraser Symmans, Ossama Tawfik, Debasish Tripathy, Megan L. Troxell, Laura J. van't Veer, Sara J. Venters, Tuyethoa Vinh, Rebecca K. Viscusi, Anne M. Wallace, Shi Wei, Amy Wilson, Douglas Yee, Jay C. Zeck
Publikováno v:
I-SPY 2 Trial Consortium 2022, ' Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients ', The Lancet Oncology, vol. 23, no. 1, pp. 149-160 . https://doi.org/10.1016/S1470-2045(21)00589-1
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
Background: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b5a03d8d05046179f5dcc364471bd0
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
Autor:
Shi Wei, Richard Schwab, Gregor Krings, Lajos Pusztai, Rashmi Krishna Murthy, Lauren LeBeau, Megan L. Troxell, Adam Asare, Erin D. Ellis, Sharon Sams, Donald A. Berry, Fang Fan, Anne M. Wallace, Andres Forero-Torres, Christina Yau, Angela DeMichele, Donald W. Northfelt, Mara H. Rendi, Laila Khazai, Husain Sattar, Xiuzhen Duan, Ronald Balassanian, Rebecca K. Viscusi, Hyo S. Han, Barbara A. Parker, A. Jo Chien, Brian Leyland-Jones, Meredith Buxton, Idris Tolgay Ocal, Yunn Yi Chen, Qamar J. Khan, Brian Datnow, Barbara Haley, Tuyethoa Vinh, Kathy S. Albain, Laura van 't Veer, Minetta C. Liu, Michael Feldman, Amy S. Clark, Kirsten H. Edmiston, W. Fraser Symmans, Sonal Shad, Kathleen Kemmer, Judy C. Boughey, Julie E. Lang, Paulette Mhawech-Fauceglia, Teresa Helsten, Douglas Yee, Molly Klein, Rita Nanda, Claudine Isaacs, Anthony D. Elias, Sara J. Venters, Nola M. Hylton, Jay Zeck, Laura J. Esserman, Beiyun Chen, Hope S. Rugo, Smita Asare, Sunati Sahoo, Jeffrey B. Matthews, Jane Perlmutter
Publikováno v:
JAMA Oncol
Importance Residual cancer burden (RCB) distributions may improve the interpretation of efficacy in neoadjuvant breast cancer trials. Objective To compare RCB distributions between randomized control and investigational treatments within subtypes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970e2b28a3f16ef394eea6cc208edc54
https://europepmc.org/articles/PMC8446908/
https://europepmc.org/articles/PMC8446908/
Autor:
Debu Tripathy, AS Clark, AD Elias, William Fraser Symmans, Je Lang, Amy Wilson, Kirsten H. Edmiston, Christos Vaklavas, Preya Shah, L.J. van 't Veer, Melanie Catherine Majure, Denise M. Wolf, Judy C. Boughey, Amy Jo Chien, M. Melisko, Nola M. Hylton, Richard Schwab, Christina Yau, Rita Nanda, Claudine Isaacs, Barbara Haley, Teresa Helsten, Donald A. Berry, HS Han, Erin D. Ellis, Erica Stringer-Reasor, Qamar J. Khan, KS Albain, Nora Jaskowiak, Erin Roesch, S Asare, AM DeMichele, HS Rugo, Cheryl Ewing, LJ Esserman, C Lee, Tufia C. Haddad, Kathleen Kemmer, Larissa A. Korde, Anne M. Wallace, Jane Perlmutter, Ruby Singhrao, D Yee, Andres Forero, Rebecca K. Viscusi, Janice Lu, Donald W. Northfelt
Publikováno v:
Cancer Research. 79:P1-15
This abstract was withdrawn by the authors. Citation Format: Schwab R, Clark A, Yau C, Wolf D, Chien AJ, Majure M, Ewing C, Wallace A, Roesch E, Helsten T, Forero A, Stringer-Reasor E, Vaklavas C, Nanda R, Jaskowiak N, Boughey J, Haddad T, Han H, Lee
Autor:
Erin D. Ellis, Shelly S. Lo, William C. Wood, C Isaacs, L Korde, Kirsten K. Edmiston, Debu Tripathy, D Yee, Je Lang, Sy Chui, MC Liu, Heather Beckwith, Rita Nanda, DW Northfelt, Kathleen Kemmer, E Price, Judy C. Boughey, L Pusztai, AS Clark, A Forero-Torres, Rita A. Mukhtar, John W. Park, KS Albain, AJ Chien, L Suleiman, HS Han, Richard Schwab, O. I. Olopade, C Yau, S. L. Moulder, R Singhrao, DM Euhus, A DeMichele, S Asare, Rebecca K. Viscusi, Donald A. Berry, Anne M. Wallace, J Lu, HS Rugo, AD Elias, J Silverstein, LJ Esserman, Teresa Helsten, QJ Khan, Brian Leyland-Jones
Publikováno v:
Cancer Research. 79:P2-14
Background: In women with breast cancer receiving neoadjuvant chemotherapy, residual cancer burden (RCB) predicts distant recurrence and survival. In those with high risk tumors, locoregional recurrence (LRR) remains a concern, and has been associate
Autor:
Juliana Liang, Albert T. Roh, Matthew B. Petterson, John R. Davis, Lisa M. Winton, Ian K. Komenaka, Ramin Jamshidi, Mary J. Connell, Laurel Kittrell, Rebecca K. Viscusi
Publikováno v:
Journal of pediatric surgery. 56(5)
Background/Purpose: Breast masses in the pediatric population cause patient and family concern, partially driven by public awareness of adult breast cancer. However, the spectrum of breast masses in children differs greatly from that in adults, and m
Autor:
Laura J. van't Veer, Kathleen Kemmer, W. Fraser Symmans, Christina Yau, Barbara Haley, Janice Lu, S Asare, Erin D. Ellis, Nora Jaskowiak, Katherine Steeg, Erica Stringer-Reasor, Anthony D. Elias, Ashish Sanil, Donald W. Northfelt, Andres Forero-Torres, Constantine Godellas, Anne M. Wallace, Nola M. Hylton, Ruby Singhrao, Laura J. Esserman, Angela DeMichele, Donald A. Berry, Richard Schwab, Jane Perlmutter, Hope S. Rugo, Garry Peterson, Debasish Tripathy, Judy C. Boughey, Michelle E. Melisko, Meredith Buxton, Gillian L. Hirst, Teresa Helsten, Douglas Yee, Larissa A. Korde, Julia L. Clennell, Amy Wilson, Rebecca K. Viscusi, Rita Nanda, Claudine Isaacs, Henry G. Kaplan, Kathy S. Albain, Rashmi Murthy, Scott M. Berry, Melissa Paoloni, Julie E. Lang, Amy S. Clark, Jeffrey B. Matthews, Kirsten K. Edmiston, A. Jo Chien
Publikováno v:
J Clin Oncol
PURPOSEThe phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin is a key pathway of survival and therapeutic resistance in breast cancer. We evaluated the pan-Akt inhibitor MK-2206 in combination with standard therapy in patients with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed9a9a2e1a4541afe98e7485020400cb
https://europepmc.org/articles/PMC7106976/
https://europepmc.org/articles/PMC7106976/
Autor:
Anthony M. Magliocco, AM DeMichele, Rashmi Krishna Murthy, Kirsten K. Edmiston, J Ritter, LJ Esserman, J Wisell, Y-Y Chen, Jane Perlmutter, Gillian L. Hirst, Erin D. Ellis, Andres Forero-Torres, G Keeney, Kathleen Kemmer, A Tipps, Jay Zeck, AS Clark, F Fan, Husain Sattar, Khalid Amin, G Krings, Ossama Tawfik, Megan L. Troxell, Susan Minton, Sunati Sahoo, Hongzheng Zhang, Stamatakos, A Adams, S Asare, AD Elias, Fraser Symmans, Mara H. Rendi, B Kallakury, Barbara Haley, Molly Klein, T Ocal, A Zelnak, L.J. van 't Veer, Michael Feldman, Sharon Sams, B Datnow, Tuyethoa Vinh, Kathy S. Albain, M Melisko, Je Lang, AJ Chien, K Gwin, Y Fang, Shuko Harada, NM Hylton, X Duan, F Hasteh, Jeffery Mueller, S Thornton, R Tickman, Shi Wei, Qamar J. Khan, N Klipfel, Larissa A. Korde, Judy C. Boughey, Awais Mansoor, Gabrielle M. Baker, Ruby Singhrao, C Ersahin, R Gamez, Donald A. Berry, D Yee, Rita Nanda, Claudine Isaacs, Donald W. Northfelt, Hyo S. Han, Rebecca K. Viscusi, Anne M. Wallace, Christina Yau, L Grasso LeBeau, R Balassanian, Beiyun Chen, N Weidner, HS Rugo
Publikováno v:
Cancer Research. 78:GS3-08
Background: Pathological complete response (pCR) is accepted by FDA as a surrogate endpoint for accelerated approval of targeted agents in combination with chemotherapy based on better long-term outcomes compared to residual disease (Cortazar 2014).
Autor:
Victor J. Gonzalez, Rajayogesh Davuluri, Robert B. Livingston, Uma Goyal, Justin Famoso, Pavani Chalasani, Lauren LeBeau, Tijana Skrepnik, Rebecca K. Viscusi, Michele B. Ley
Publikováno v:
Oncomedicine. 2:61-65
Autor:
Jonida Krate, Hang T. Ho, Rebecca K. Viscusi, Melissa H. Tran, William J. Adamas-Rappaport, Hilary C. McCrary, Christine E. Savilo
Publikováno v:
The American Journal of Surgery. 212:1020-1025
Background The aim of our study was to determine if a fresh cadaver model is a viable method for teaching ultrasound (US)-guided breast biopsy of palpable breast lesions. Methods Third-year medical students were assessed both preinstruction and posti